Abstract 11720: Efficacy and Safety of Apixaban versus Rivaroxaban in Acute Venous Thromboembolism: A Systematic Review and Meta-Analysis
Introduction: Apixaban and rivaroxaban are commonly used direct oral factor Xa inhibitors for acute venous thromboembolism (VTE), but uncertainty remains about their comparative effectiveness and bleeding risk across general and cancer-associated VTE populations. Research Question: We evaluated whether apixaba...